Click here to register!
Join us on November 22nd for #TalkBD – Psychedelics & Bipolar! At this online community gathering, Dr. Josh Woolley and Amir will join us to discuss psychedelics and bipolar disorder: the state of the research, their current project, and future directions. They’ll also be taking your questions!
We welcome anybody interested in this topic to join us for the event!
Where to Join
Date and Time: Monday, November 22nd, 12-1pm PST, 4pm EST, 8pm GMT (Find what time this is for me)
Zoom Link: zoom.us/webinar/register/WN_0mV3ll88TXKOloyjT-NMoQ
Link to watch as a livestream: TalkBD.live or our our Facebook page
Josh Woolley, MD, PhD
Associate Professor, Department of Psychiatry and Behavioral Sciences, University of California, San Francisco
crestbd.ca/josh / @thebandlab
Dr. Josh Woolley is currently the principal investigator and director of UCSF’s Bonding and Attunement in Neuropsychiatric Disorders (BAND) Laboratory. The lab’s mission is to understand mechanisms of social connection among individuals with mental illness and to test new treatments. The BAND Lab studies psychedelics as novel therapeutics for multiple conditions, including bipolar disorder. He’s also the director of the translational psychedelic research program at UCSF.
Peer researcher, BSc
Amir is a recent graduate of UBC in a bachelors of science in cognitive systems where he focused on cognition and the brain. He is a peer researcher at Crest.BD and is starting his role as a peer mental health support worker at Foundry. As an individual with lived experience, he has been a researcher on UBC and UCSF’s joint project on investigating the use of Psilocybin in individuals with bipolar disorder.
Dr. Erin Michalak
Erin is the Founder and Network Lead of CREST.BD, and Professor at UBC Psychiatry. Her research in mental health, patient-oriented research and quality of life in bipolar disorder is globally recognized. Erin spearheaded the development of the first BD-specific quality of life scale, the QoL.BD. The QoL.BD has seen rapid uptake internationally and is now the gold-standard for BD quality of life assessments. Under Erin, CREST.BD also launched an online version of the QoL.BD, and the Bipolar Wellness Centre, a web portal of scientifically validated wellness strategies for BD. In 2018, she was awarded the CIHR Gold Leaf Prize for Transformation in Patient Engagement.